Edition:
United States

AGNC Investment Corp (AGNC.OQ)

AGNC.OQ on NASDAQ Stock Exchange Global Select Market

18.84USD
23 Feb 2018
Change (% chg)

$0.24 (+1.29%)
Prev Close
$18.60
Open
$18.68
Day's High
$18.89
Day's Low
$18.67
Volume
534,845
Avg. Vol
1,092,591
52-wk High
$22.34
52-wk Low
$17.94

Chart for

About

AGNC Investment Corp., formerly American Capital Agency Corp., is a real estate investment trust. The Company invests in agency residential mortgage-backed securities on a leveraged basis. Its investments consist of residential mortgage pass-through securities and collateralized mortgage obligations (CMOs) for which the... (more)

Overall

Beta: -0.01
Market Cap(Mil.): $7,372.01
Shares Outstanding(Mil.): 391.30
Dividend: 0.18
Yield (%): 11.61

Financials

  Industry Sector
P/E (TTM): -- 41.66 16.59
EPS (TTM): -- -- --
ROI: -- 7.13 35.07
ROE: -- 12.81 17.79

BRIEF-AGNC Investment Corp Reports 5.7 Pct Stake In MTGE Investment Corp

* AGNC INVESTMENT CORP REPORTS 5.7 PERCENT STAKE IN MTGE INVESTMENT CORP AS OF FEBRUARY 14 - SEC FILING

Feb 22 2018

BRIEF-AGNC Investment Reports Qtrly Earnings Per Share $0.96

* AGNC INVESTMENT CORP. ANNOUNCES FOURTH QUARTER 2017 FINANCIAL RESULTS

Jan 31 2018

BRIEF-Bernice Bell To Be Promoted To Senior VP And CFO of AGNC Investment

* AGNC INVESTMENT CORP - BERNICE BELL WILL BE PROMOTED TO SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

Dec 18 2017

BRIEF-AGNC Investment reports Q3 ‍net interest income $178 mln

* AGNC Investment Corp. Announces third quarter 2017 financial results

Oct 25 2017

IFR Americas ECM Pipeline

Sept 13, 2017 - PRICED AGNC Investment (US, Mortgage REIT) – $510.8m Block. 24.5m shares (100% prim) at $20.85 versus $20.75-$20.95 marketing range and $21.50 last sale. CS, JPM, MS, UBS, WF. BioCryst Pharmaceuticals (US, biotech) – $80m FO. 15.5m (100% prim) at $5.15 versus $5.23 last sale and $5.75 launch JPM, BARC. Grupo Supervielle (Argentina, bank) – $412m FO. 20.6m ADS (68% prim, 32% sec) at $20.00 versus $20.56 last sale and $22.00 at launch. BAML, ITAU, JPM. Portola Pharmaceuticals (US,

Sep 13 2017

BRIEF-AGNC Investment announces pricing of public offering of common stock

* AGNC Investment Corp. announces pricing of public offering of common stock

Sep 13 2017

BRIEF-AGNC Investment announces public offering of 24.5 mln common stock

* AGNC Investment Corp announces public offering of common stock

Sep 12 2017

Earnings vs. Estimates